참고문헌
- Textbook Compilation Committee of Korean dermatological association. Dermatology. 6th ed. Seoul:Yeomoongak. 2014:299-314.
- Clarke P. Psoriasis. Aust Fam Physician. 2011;40(7):468-73.
- Shanu KK, Andrea BT, Paul CC, Joel MG. The risk of depression, anxiety, and suicidality in patients with psoriasis. Arch Dermatol. 2010;146(8):891-5. https://doi.org/10.1001/archdermatol.2010.186
- Nancy W, Sarah M. Psoriasis. Am Fam Physician. 2013;87(9):626-33.
- Kim NK, Hwang CY, Lim GS. The oriental and occidental bibliographic study of Psoriasis. J Korean Med Ophthalmol Otolaryngol Dermatol. 1999;12(1):154-78.
- Youn SW. The Assessment of Psoriasis Severity: PASI, BSA, DLQI. Journal of the Korean Society for Psoriasis. 2013;10(1):11-4.
- Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41:401-7. https://doi.org/10.1016/S0190-9622(99)70112-X
- Wahl A. The impact of psoriasis on psychosocial life domains;A review. Scand J Caring Sci. 1997;11:243-9. https://doi.org/10.1111/j.1471-6712.1997.tb00463.x
- Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146:89-95.
- Choi JH. Pruritus in Psoriasis. The Korean Society for Skin Barrier Research. 2009;11(2).
- Gupta MA, Gupta AK, Kirkby S, Weiner HK, Mace TM, Schork NJ, et el. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124:1052-7. https://doi.org/10.1001/archderm.1988.01670070040016
- Yeilding N, Szapary P, Brodmerkel C, Benson J, Plotnick M, Zhou H, et al. Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives. Ann NY Acad Sci. 2011;1222:30-9. https://doi.org/10.1111/j.1749-6632.2011.05963.x
- Kim JY, Lee WJ, Lee SJ, Kim DW, Kim TH, Jun JB, et al. An Investigation on the Use of Complementary and Alternative Medicine for Psoriasis. Korean Journal of Dermatology. 2010;48(6):494-502.
- Hong SH. Reviewing Research on Korean medical treatment of Psoriasis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2013;26(4):26-42. https://doi.org/10.6114/jkood.2013.26.4.026
- Na SJ, Jo SJ, Youn JI. Clinical observation of the patients registered or the past 30 years (1982-2012) at Seoul National University Hospital Psoriasis Clinic. J Dermatol. 2013;40(9):731-5. https://doi.org/10.1111/1346-8138.12224
- Carlin CS, Feldman SR, Krueger JG, Menter A, Krueger GG. A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol. 2004;50(6):859-66. https://doi.org/10.1016/j.jaad.2003.09.014
- Kim SY, Yun SJ, Lee JB, Kim SJ, Won YH, Lee SC. A Comparison of Efficacy and Adverse Reactions between Methotrexate and Cyclosporine A. Korean Journal of Dermatology. 2014;52(9):615-21.
- Lim JH, Woo YR, Kim MR, Park HJ. The Effect of Combination Treatment with Ustekinumab and Topical Agents in Korean Patients with Moderate-to-severe Psoriasis: A Retrospective Study of 30 Patients through 5 Years of Follow Up. Korean Journal of Dermatology. 2017;55(3):171-7.
- Yang JI, Lee KH, Kim YS, Shin MK, Yoo JH, Chang GT. A Report on Liver Function Tests of 82 Psoriasis Patients Taking Herbal Medication over 3 Months. J Korean Oriental Med. 2012;33(3):95-104.
- Lee BC, Cho EJ. The Safety and Efficacy of Herbal Medicine for 107 Psoriasis Patients: A Retrospective Chart Review. J Korean Med. 2016;37(1):34-40. https://doi.org/10.13048/jkm.16004
- Roh HJ, Bae BG, Lee JH. Recent Advances in Topical Therapy of Psoriasis. Journal of the Korean Society for Psoriasis. 2009;6(1):1-6.